{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:28:52Z","timestamp":1790180932945,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Circassia Ltd"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.rmed.2019.07.010","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T01:58:29Z","timestamp":1562378309000},"page":"54-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Scottish consensus statement on the role of FeNO in adult asthma"],"prefix":"10.1016","volume":"155","author":[{"given":"Chris RuiWen","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Spears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Haughney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8140-2014","authenticated-orcid":false,"given":"Brian","family":"Lipworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rmed.2019.07.010_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1164\/ajrccm.157.2.96-08040","article-title":"Airway inflammation in mild intermittent and in persistent asthma","volume":"157","author":"Vignola","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9347","key":"10.1016\/j.rmed.2019.07.010_bib3","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.[see comment]","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmed.2019.07.010_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1378\/chest.11-1748","article-title":"A randomized primary care trial of steroid titration against mannitol in persistent asthma: STAMINA trial","volume":"141","author":"Lipworth","year":"2012","journal-title":"Chest"},{"issue":"4 Pt 1","key":"10.1016\/j.rmed.2019.07.010_bib5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1164\/ajrccm.159.4.9806052","article-title":"Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group","volume":"159","author":"Sont","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2019.07.010_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cea.12881","article-title":"The current and future role of biomarkers in type 2 cytokine-mediated asthma management","volume":"47","author":"Pavord","year":"2017","journal-title":"Clin. Exp. Allergy"},{"issue":"4","key":"10.1016\/j.rmed.2019.07.010_bib7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaci.2013.06.007","article-title":"Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects","volume":"132","author":"Malinovschi","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.rmed.2019.07.010_bib8","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.rmed.2019.07.010_bib9","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.rmed.2019.07.010_bib10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2222.2008.02969.x","article-title":"IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells","volume":"38","author":"Chibana","year":"2008","journal-title":"Clin. Exp. Allergy"},{"issue":"8 Pt 1","key":"10.1016\/j.rmed.2019.07.010_bib11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/ajrccm.164.8.2101145","article-title":"Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone","volume":"164","author":"Payne","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2019.07.010_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/thx.53.2.91","article-title":"Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma","volume":"53","author":"Jatakanon","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2019.07.010_bib13","series-title":"Asthma: Diagnosis, Monitoring and Chronic Asthma Management (NG80)","author":"National Institute for Health and Care Excellence","year":"2017"},{"issue":"6","key":"10.1016\/j.rmed.2019.07.010_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/thorax.58.6.494","article-title":"Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma","volume":"58","author":"Malmberg","year":"2003","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.rmed.2019.07.010_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00616-2018","article-title":"Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: the Copenhagen General Population Study","volume":"52","author":"Colak","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2019.07.010_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01433-2017","article-title":"Un-diagnosing persistent adult asthma","volume":"50","author":"Lipworth","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2019.07.010_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9343(99)00435-0","article-title":"Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma","volume":"108","author":"Wilson","year":"2000","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2019.07.010_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1378\/chest.11-0392","article-title":"Fluticasone\/Salmeterol combination confers benefits in people with asthma who smoke","volume":"141","author":"Clearie","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2019.07.010_bib19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1034\/j.1399-3003.1999.14d28.x","article-title":"Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis","volume":"14","author":"Gratziou","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2019.07.010_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0194599812442322","article-title":"Exhaled nitric oxide measurement in patients affected by nasal polyposis","volume":"147","author":"Galli","year":"2012","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"6","key":"10.1016\/j.rmed.2019.07.010_bib21","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1378\/chest.12-1310","article-title":"Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial","volume":"142","author":"Anderson","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2019.07.010_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.anai.2016.11.018","article-title":"Inhaled corticosteroid dose response in asthma: should we measure inflammation?","volume":"118","author":"Anderson","year":"2017","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2019.07.010_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/cea.13057","article-title":"Blood eosinophils: the forgotten man of inhaled steroid dose titration","volume":"48","author":"Jabbal","year":"2018","journal-title":"Clin. Exp. Allergy"},{"issue":"8","key":"10.1016\/j.rmed.2019.07.010_bib24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1034\/j.1398-9995.2003.00226.x","article-title":"Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate","volume":"58","author":"Currie","year":"2003","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2019.07.010_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S2213-2600(17)30424-1","article-title":"Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial","volume":"6","author":"Price","year":"2018","journal-title":"The Lancet. Respiratory medicine"},{"issue":"12","key":"10.1016\/j.rmed.2019.07.010_bib26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thoraxjnl-2018-211540","article-title":"Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis","volume":"73","author":"Petsky","year":"2018","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.rmed.2019.07.010_bib27","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201204-0587OC","article-title":"The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma","volume":"186","author":"McNicholl","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2019.07.010_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/rccm.201806-1182OC","article-title":"Remotely monitored therapy and nitric oxide suppression identifies non-adherence in severe asthma","volume":"199","author":"Heaney","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.07.010_bib29","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.rmed.2019.07.010_bib30","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.rmed.2019.07.010_bib31","author":"National Institute for Health and Care Excellence"},{"issue":"8","key":"10.1016\/j.rmed.2019.07.010_bib32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9842","key":"10.1016\/j.rmed.2019.07.010_bib33","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.rmed.2019.07.010_bib34","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.rmed.2019.07.010_bib35","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.rmed.2019.07.010_bib36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-2600(18)30201-7","article-title":"Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial","volume":"6","author":"Russell","year":"2018","journal-title":"The Lancet. Respiratory medicine"},{"issue":"3","key":"10.1016\/j.rmed.2019.07.010_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1398-9995.2008.01855.x","article-title":"An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom","volume":"64","author":"Price","year":"2009","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.rmed.2019.07.010_bib38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jaci.2014.07.016","article-title":"Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: a cluster-randomized trial in primary care","volume":"135","author":"Honkoop","year":"2015","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119302306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119302306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:51:33Z","timestamp":1760615493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119302306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":37,"alternative-id":["S0954611119302306"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.07.010","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scottish consensus statement on the role of FeNO in adult asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}